Johnson & Johnson Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (148)

Latest Posts

About This Stock More About This Stock
IBB – Challenging 2016, Recovering 2017 And Resurgence In 2018
Article By: Noah Kiedrowski
Tuesday, February 6, 2018 3:12 PM EST
The Biotechnology cohort has finally notched a 52-week high and has made up much of the lost ground during the pummeling from both sides of the political isle during the 2016 presidential race.
In this article: AGN, JNJ, NVO, IBB, REGN, GILD, JUNO, ABBV, KITE
Read
J&J Q4 Earnings Top, Pharma Sales Continue To Improve
Article By: Zacks Investment Research
Tuesday, January 23, 2018 11:30 AM EST
Johnson & Johnson fourth-quarter 2017 earnings came in at $1.74 per share.
In this article: JNJ Also: GSK, MRK, ABBV
Read
Johnson & Johnson (JNJ): A Dividend King That’s Built To Last
Article By: Simply Safe Dividends
Sunday, January 21, 2018 12:00 PM EST
Very few businesses ever come close to growing as large as Johnson & Johnson has become with more than $70 billion in annual revenue.
In this article: JNJ
Read
EC Q4 Earnings Season: Strong Growth, But Weak Quality
Article By: Sheraz Mian
Saturday, January 20, 2018 6:24 PM EST
A lot goes into ‘earnings quality’. But as a general rule, it is reasonable to be wary of a big variance between adjusted and GAAP earnings. Going by this simple rule, you have to question the ‘quality’ of Q4 earnings reports.
In this article: TXN, UAL, VZ, PG, NFLX, SBUX, JNJ, INTC, MMM, GE, HON, IBM
Read
Week In Review: Sinocare Eyes $4 Billion Deal For J&J Diabetes Device Business
Article By: ChinaBio® Today
Saturday, January 20, 2018 5:34 PM EST
Sinocare, a diabetes company based in Changsha, may bid as much as $4 billion to acquire Johnson & Johnson's diabetes medical device subsidiaries. With falling revenues, some of J&J's diabetes-focused companies are exiting from the US market.
In this article: JNJ, LLY, CELG, BGNE, MRTX, AMRN
Read

PARTNER HEADLINES

Latest Tweets for $JNJ

No tweets yet!